BACKGROUND: Patient decision aids facilitate informed decision making for medical tests and procedures that have uncertain benefits. OBJECTIVE: To describe participants' evaluation and utilization of print-based and web-based prostate cancer screening decision aids that were found to improve decisional outcomes in a prior randomized controlled trial. DESIGN: Men completed brief telephone interviews at baseline, one month, and 13 months post-randomization. PARTICIPANTS: Participants were primary care patients, 45-70 years old, who received the print-based (N=628) or web-based decision aid (N = 625) and completed the follow-up assessments.
INTRODUCTION
Patient decision aids are important tools that can facilitate informed and shared decision making for medical tests and procedures that have uncertain benefits, such as prostate cancer screening. 1 Cancer-related organizations, as well as the US Preventive Services Task Force, have encouraged patients to engage in informed and shared decision making with their physician about prostate cancer screening, rather than engage in routine, annual screening. [2] [3] [4] Men have also expressed a desire for shared decision making for prostate cancer screening 5, 6 and a need for more information about prostate cancer. 7 We recently completed a randomized controlled trial to test the impact of a print-based and a web-based decision aid for prostate cancer screening on behavioral and screening outcomes. 8 Users of each decision aid demonstrated better prostate cancer knowledge, less decisional conflict, and more satisfaction with their screening decision than usual care participants. Print and web users differed only on satisfaction with the decision: print users were more likely to be satisfied with their decision than web users. Screening behavior was not impacted by either decision aid at 13 months post-randomization.
In the present paper, we describe men's assessment of the decision aids and factors that predicted their use and understanding of the tools. Evaluations such as these can help to assess intervention quality, 9 understanding of participants' reception of the intervention, 10 and guide future dissemination of the intervention. 10 Previous trials of decision aids for prostate cancer screening have reported very favorable participant ratings of decision aid clarity and helpfulness. [11] [12] [13] [14] [15] [16] Decision aid content was typically rated as neutral (i.e., neither encouraging nor discouraging screening) compared to usual care. [11] [12] [13] 16 Although these studies evaluated patient responses to decision aids, we are aware of no study that has assessed the potential influence of demographic and clinical variables on the likelihood of using and understanding the materials.
We present the results of an in-depth evaluation comparing our print-based and web-based decision aids, including rates of use, patient preference for the decision aid medium, the impact of the decision aids on patient-physician communication, and men's understanding of the decision aids' primary message. Due to lower health literacy among older adults, minorities, and less educated adults, 17 we expected that age, race, and education would be significant predictors of decision aid use. We also expected that when men's baseline preference for web versus print materials matched their randomly assigned decision aid, they would be more likely to use the decision aid.
METHODS

Subjects.
A detailed description of the subjects and procedures was previously presented. 8 Briefly, eligibility criteria included: men 45-70 years old, no history of prostate cancer, Englishspeaking, ability to provide informed consent, living independently, and having had a primary care outpatient visit within 24 months prior to recruitment. Eligibility was not based on having an upcoming office visit or on having Internet access.
Procedure. This study was approved by the Georgetown/ Medstar Oncology Institutional Review Board. We mailed invitation letters to eligible subjects ( Fig. 1 ) and men were subsequently called to confirm eligibility, obtain verbal consent, and to complete the 20-minute baseline telephone interview. At the conclusion of the baseline interview, the interviewer used a computer-generated random allocation sequence to assign participants to the web (N=625), print (N=628), or usual care (N=626) arms. We then mailed participants a written consent form along with either the booklet (print arm) or login information and website URL (web arm). We encouraged men to review the materials prior to the one -month interview. The usual care arm received no decision aid intervention, and therefore will not be described further in this paper. We conducted follow-up telephone assessments at one month and 13 months post-baseline. Data were collected from November 2007 to January 2010.
Description of the Intervention Arms. The two decision aids provided identical content, including facts about the prostate gland and prostate cancer, the benefits and limitations of screening, and the risks and side effects of prostate cancer treatment and monitoring options. The web-based decision aid included six video testimonials that were presented in pairs, one of which focused on the potential benefits of screening and the other on the potential harms of screening. Further, the decision aids encouraged shared decision making with physicians and included a values clarification tool (a ten-item scale on which men identified their preferences about screening). On the web-based decision aid, the questions comprising the values clarification tool appeared at intervals throughout the website and a summary of the responses were presented on a subsequent page. In the print-based decision aid, the values clarification tool was a worksheet that asked all ten questions on one page at the end of the booklet. More information about the decision aids is available. 18, 19 Measures Descriptive Variables. We assessed demographics (age, race, education level, employment, income, whether men had a regular physician, insurance, and numeracy 20 ) and clinical characteristics (comorbidities, personal history of cancer, family history of prostate cancer, prostate cancer screening history in one's lifetime and in the year prior to trial enrollment), and recollection of a prior discussion of prostate cancer screening with a physician.
Decision Aid Evaluation Variables. At baseline, telephone interviewers assessed men's preference for print-based versus web-based health information, and Internet access and use. We used a series of questions to assess patients' evaluation of decision aids from our prior work assessing other decision aids 16, 18 and incorporated other studies' prostate cancer screening decision aid evaluations. 11, 12 At the one-month interview, we assessed self-reported use of the materials, ratings of the content, patient-physician communication about the materials, and reasons for not using the materials (see Kassan et al. for web use based on electronic tracking data 19 ). At the 13-month interview, we assessed men's self-reported use of the materials and patient-physician communication since the one-month follow-up. We created a 3-level variable indicating the agreement between baseline preference for print-based versus web-based materials and randomization arm: 1) baseline preference matched randomization assignment, 2) baseline preference did not match randomization assignment, and 3) those with no baseline preference for either web-based or print-based materials.
Data Analyses
We conducted chi-square tests and ANOVAs to assess for group differences on demographics, clinical characteristics, Internet access, and decision aid evaluation variables. These analyses included participants who completed both the baseline and one-month assessments. Assessment of the 13-month evaluation variables included participants who completed all three assessments. Next, we determined the significant covariates (demographic and clinical characteristics) to include in the logistic regression models, which were age, race, education, screening history prior to enrollment in the trial, and frequency of Internet use. Finally, we conducted logistic regression models to determine the significant predictors of 1) understanding the overall message of the decision aids and 2) decision aid use, separately for web and print arms. Figure 1 presents the study flow chart, the participation rate, and the sample size at each assessment. In Table 1 , we present participants' demographic and clinical characteristics for all participants who completed both the baseline and one-month assessments, stratified by users and non-users within each arm. Compared to non-users, decision aid users in both arms were significantly more likely to be white, highly educated, employed, to have a higher income, and to have answered both numeracy questions correctly. Men who did not use the decision aid in the web arm reported significantly more comorbidities, and users of the website were significantly more likely to have been screened and to have discussed prostate cancer screening with their physician.
RESULTS
Descriptive Information
Baseline Education Preferences and Web Access
At baseline, there was an overall preference for receiving a print-based decision aid (51.7 %) over a web-based decision aid (36.6 %; p <0.001). However, there were no significant group differences regarding preferences for web-or print-based health education materials at baseline) (p=0.79; Table 2 ). The majority (90.8 %) had Internet access, and of those, almost all (94.7 %) had a highspeed connection and 70.3 % used the Internet daily. Importantly, there were no significant differences between web and print arms on web access variables (assessed at baseline). Most Internet users (96 %) reported that they used the Internet to obtain health-related information at least a few times a year. Of the 99 men without Internet access, 59.2 % were willing to access the website if assigned to the web arm (e.g., at a friend's house). For all other analyses, African-American and other races were collapsed into one 'non-white' category. The users and nonusers in both categories still differed significantly (both p's<0.001) ‡ The N value does not add up to the total due to missing data PCa prostate cancer; RCT randomized controlled trial
Decision Aid Evaluation Variables
Use of the Booklet and Website. Table 3 Decision Aid Content. Very few participants reported having problems understanding the materials or that the decision aid made them nervous/fearful about screening ( Table 3 ). The majority (79 %) considered the materials very or extremely helpful in understanding the pros and cons of screening, and over 40 % of men in each arm said that the decision aid was influential in their screening decision. Importantly, almost 65 % of the entire sample understood that screening is an individual decision and that the information in the materials was not making a recommendation either for or against screening, with the web arm users more likely to understand this message than print arm users (68.2 % vs. 61.9 %; p<0.01). However, in a logistic regression analysis controlling for race, education, and frequency of Internet use, we found no group differences regarding comprehension of this message (OR= 0.87, 95 % CI: 0.63, 1.21).
Patient-Physician Communication. In each arm, about onehalf of men said that the decision aid raised new questions to ask their physician (Table 3) . Over 80 % in each arm indicated they would prefer to receive decision aid materials prior to a physician's visit, with web users significantly more likely than print users to prefer pre-visit materials (p<0.001).
At one month, 94 % said they had not discussed their thoughts and concerns regarding prostate cancer screening with their physician since reading the materials; this was likely due to men not having had a primary care appointment between review of the decision aid and the one-month interview. However, at 13 months, over 40 % in each arm reported discussing prostate cancer screening with their physician.
Non-Users of the Decision Aids. At the one-month assessment, 288 (26.8 %) men reported that they did not use their assigned decision aid (print arm: n=99, web arm: n=189; Table 3 ). The most frequently cited reasons were lack of time and lack of interest, and for web participants, lack of Internet access. 
Predictors of Decision Aid Use at the One-Month Follow-up
In unadjusted analyses, we assessed whether men's baseline preference for web-based vs. print-based materials impacted decision aid use (Fig. 2) . Use of the website was significantly lower among those who did not receive their preferred medium (52.3 %), compared to those who did receive their preferred medium (78.6 %) or had no preference (73.0 %; p<0.001; Fig. 2 ). However, use of the print materials was higher among those who did not receive their preferred medium (87.5 %), compared to those who did receive their preferred medium (77.0 %) or had no preference at baseline (85.2 %; p=0.01; Fig. 2 ). Logistic regression analyses revealed several significant predictors of decision aid use at the one-month assessment (Table 4) . Among print arm participants, decision aid use was more likely among white compared to non-white men (OR: 2.13, CI: 1.28, 3.54) and among men with graduate-level education compared to high school or less (OR: 2.37, CI: 1.12, 5.00). Contrary to the unadjusted analyses presented above, having a baseline preference for print materials did not significantly impact decision aid use (Table 4) Confirming the unadjusted analyses presented above, men were almost twice as likely to use the website when the website was their preferred medium (OR=1.91, CI: 1.17, 3.12; Table 4 ). When removing web arm participants who reported not having Internet access at any location (n=44), men were still more likely to use the website when the website was their preferred medium (OR=1.77, CI: 1.08, 2.90).
DISCUSSION AND CONCLUSION
These analyses revealed several notable findings with regard to men's evaluation and utilization of print-based and webbased prostate cancer screening decision aids. First, almost *Due to the skewed distribution of time spent on the website, we compared median times spent on the website with the Kruskal-Wallis test † Participants who answered this question completed all three assessments (baseline, one month, and 13 months) ‡ Participants who answered this question completed all three assessments (baseline, one month, and 13 months) and also self-reported using a decision aid § The N value does not add up to the total due to missing data PCa prostate cancer; PCP primary care physician 75 % of participants utilized a decision aid, which is notable given that the decision aids were not delivered in conjunction with a physician visit. Second, 65 % of the sample understood that the materials were not recommending either for or against screening, which is an increase in understanding from previous decision aid studies. 12, 14, 16 Third, men were significantly more likely to use the print-based compared to the web-based decision aid. However, we also found evidence that use of the decision aid was impacted by receiving one's preferred decision aid medium: in multivariable models, use of the web-based decision aid was significantly greater among those who preferred web-based materials, while use of the print-based decision aid was not associated with a preference for print materials. Fourth, we found evidence of the digital divide, as race and education were independently associated with use of the print-based decision aid, and age, race, and frequency of internet use were independently associated with use of the web-based decision aid in multivariable analyses. Thus, the medium through which information is delivered, patient preferences for the medium, and patient characteristics are all important factors to consider when delivering tools for helping patients to make an informed medical decision.
To maximize use of decision aids, these results suggest the importance of understanding the target audience's preference for different media. It also appears that there is still an important role for print-based decision aids: men who did not receive their preferred medium used the print decision aid at a much higher rate than they used the web-based decision aid. Further, there was an overall preference (51.7 %) for print-based materials when asked at baseline, despite the fact that over 90 % of participants had Internet access and over 70 % of the men who had Internet access used the Internet daily. When it is not feasible to offer more than one type of decision aid, our results suggest that print-based decision aids may reach a greater proportion of participants. However, we found that the digital divide variables of race and education impacted the use of the print materials, indicating that efforts are still needed to address these factors that have long hampered health education and informed decision making. In particular, white men were over twice as likely to use either decision aid compared to nonwhite men, corroborating previous findings suggesting that African-American and other non-white men may be somewhat reluctant to engage in medical decision making. 21, 22 This finding also reinforces the need for physicians and other clinicians to engage in culturally relevant shared decision making.
Similar to prior studies, participants rated the decision aids favorably for clarity and helpfulness. While participants in the print arm reported that the decision aid was a better length than participants in the web arm, we found few differences between the print and web arms. 15 For example, men in each arm had a similar response to the patient-physician communication outcomes and to the decision aid content, with few people reporting difficulty understanding the information and most reporting that the decision aids were very or extremely helpful. In multivariable, adjusted analyses, men were equally likely to understand that the overall message of the decision aid was neutral with regard to screening. However, there were a few important differences, in that men in the web arm were significantly more likely to: 1) use the values clarification tool, 2) spend more time using the decision aid (as well as think it was too long), and 3) prefer to receive the decision aid prior to their primary care appointment. This information can help guide informed and shared decision making by providing decision aids prior to the physician appointment, a suggestion echoed by a recently convened multi-disciplinary panel on improving shared decision making in prostate cancer screening. 23 Additionally, efforts to increase men's use of the values clarification tool in the print arm may benefit from the integration of values clarification questions throughout the decision aid, rather than as a single worksheet. Men in the web arm used the values clarification tool at higher rates than men in the print arm, likely because values clarification questions appeared throughout the website and were summarized at the end, while in the print arm, questions were presented on a single worksheet at the end of the booklet.
The primary study limitation was the necessary reliance on participants' self-reported use of the decision aids. In the web arm, we compared the self-report data with the results from the tracking software and found some overestimation of decision aid use, 19 suggesting the possibility that both arms may have overestimated their use of the decision tools. However, we are unaware of any reason to expect that the degree of overestimation would differ between groups. Another study limitation was the overall participation rate of 39.5 %. However, this rate is typical of decision aid studies that enrolled participants by mail and telephone as opposed to in conjunction with an office visit, 11, 15 and has the advantage of yielding a sample that is potentially more generalizable, as participants had fewer eligibility restrictions.
In summary, we found that decision aid use was greater in the print arm, but that use was impacted by receiving the decision aid in one's preferred medium. Variables associated with the digital divide were predictive of use of both the print and the web-based decision aids. With a recent survey of primary care physicians reporting that 80 % routinely discuss prostate cancer screening with their patients, 24 it is important to assist patients and physicians in their efforts to engage in informed and shared decision making. These results suggest that delivery of tools for informed decision making should include an assessment of patient preferences for the decision tool medium, and as well as a continued focus on patient characteristics that may limit their use.
